Skip to main content
Presentation
Neoadjuvant gemcitabine and nab-paclitaxel followed by concurrent capecitabine and radiation efficacy in borderline resectable (BR) pancreatic cancer
Journal of Clinical Oncology
  • Niraj K. Gupta
  • Kirpal Singh
  • Timothy Glass
  • Chad Davis
  • Mark Lybik
  • Christopher Leagre
  • Robert H. Liebross
  • Thomas Dugan
  • Mark Edwards
  • Stanley Givens
  • Julia Compton
  • Thomas Tigges
  • Vincent Flanders
  • Vinay Mathavan
  • Andrew Isch
  • David J. Reeves, Butler University
  • Gabriel Arevalo
  • Michael Rowe
  • Douglas Kaderabek
  • Maurice Arregui
Document Type
Conference Proceeding
Publication Date
1-1-2016
Additional Publication URL
http://meetinglibrary.asco.org/content/166144-176
Abstract
Published abstract from the 2016 ASCO Annual Meeting.
Rights
Link leads to abstract.
Citation Information
Niraj K. Gupta, Kirpal Singh, Timothy Glass, Chad Davis, et al.. "Neoadjuvant gemcitabine and nab-paclitaxel followed by concurrent capecitabine and radiation efficacy in borderline resectable (BR) pancreatic cancer" Journal of Clinical Oncology Vol. 34 (2016)
Available at: http://works.bepress.com/david-reeves/3/